Publication 08.09.2025

European Sovereignty:
the case of listed equities

Cécile Cabanis

Raphaël Thuin

Head of Capital Markets Strategies, Tikehau Capital

Thomas Friedberger

Nina Majstorovic

Investment Specialist, Capital Markets Strategies, Tikehau Capital

Tikehau Banner
At a glance

The turbulence of recent years, including the Covid-19 pandemic, geopolitical tensions, shifting alliances and stagnating growth, underline the urgency for Europe to strengthen its autonomy and resilience. At Tikehau Capital, we have been engaged in financing the European economy, positioning ourselves at the heart of the real economy and closely involved in its evolving dynamics since 2004. Indeed, with nine European offices that enable us to identify opportunities locally, we have been able to innovate and establish ourselves as a leader in private assets investment.

Building on this proven track record, we have extendedour know-how in 2023 into the listed equities space by launching Tikehau European Sovereignty Fund ("TESF"), to provide a comprehensive, 360-degree approach to this megatrend..

Register to attend in person

Highlights

Defence plays an important and rising role in securing the continent and strengthening domestic production. Indeed, ongoing conflict (...) has emphasized the importance of strengthening defence capabilities across Europe, and called for greater investment, both at the national and EU levels.

In an increasingly uncertain global landscape, European industrial autonomy is emerging as a strategic imperative, as it appears critical to reduce dependency on external suppliers, enhancing economic resilience and fostering innovation.

Financing and modernising critical infrastructures (transport, finance, energy networks, etc.) not only fosters economic growth but also reduces Europe’s dependency on foreign actors, strengthening strategic autonomy. If we look at energy for example, modernising energy infrastructures could save billions in import costs by increasing renewable energy capacity and energy efficiency.

It is critical for Europe to catch up on technological innovation, to bridge the gap with the US..

According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India.

Publication